Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Condition:   Asthma
Interventions:   Drug: Albuterol Spiromax;   Drug: ProAir HFA;   Drug: Placebo
Sponsors:   Teva Pharmaceutical Industries;   Teva Pharmaceutical Industries
Not yet recruiting – verified July 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.